BCL2L1 and acute myeloid leukemia: Anti-apoptotic proteins like Bcl-2 and Bcl-xL were markedly upregulated in different types of leukemia malignancies, especially in more advanced MDS and in newly diagnosed AML, when compared to normal samples or AML patients under complete remission [76].